Como se describi anteriormente en efectos sobre MACE, AR GLP-1 RA reduce principalmente los resultados asociados con ECV, como infarto de miocardio, accidente cerebrovascular y muerte cardiovascular, mientras que SGLT2i conduce a una reduccin pronunciada en el riesgo de muerte cardiovascular y IC, pero tambin reduce el infarto de miocardio
That could mean $1,000 to $1,200+ per month at list price
Data availability The datasets generated and analyzed during this study are included in the Supplementary files
This offer is not valid for prescriptions covered by or submitted for reimbursement, in whole or in part, under Medicare, Medicaid, VA, DOD, TRICARE, similar federal or state programs, including any state pharmaceutical programs
At this years USDA Agricultural Outlook Forum panel, some suggested slowing food demand from both GLP-1 drugs and slowing population growth may require agriculture to increase its focus on nutritionally dense food, rather than production volume (Hagstrom, 2025)
I mean, it sounds like a battleship or something, but what is this BPC 157